We can help your business to:
For assets in the preclinical to Phase 2 space evaluating the opportunity and planning the best development path to patient and market becomes a priority. The VPA POEM group can help to maximise the value of assets by providing an integrated view of the therapeutic area landscape, the competition, the development options and challenges, the regulatory path, and commercial considerations and risks. Additionally for those looking to acquire or license assets we can provide Due Diligence services with full valuation, deal terms, and legal and IP guidance.
Graham Finch BSc BEng MSc
Practice Lead POEM
Graham is a consultant to biopharmaceutical organisations providing strategic and analytical guidance to Research and Development and Business Development investment decisions. He has a background in product and portfolio strategy, commercial ana...read more